网络医学信息化的多组学集成识别了氨缩性侧面硬化症的药物标和可重复使用的药物
Mucen Yu1,2,3, Jielin Xu1,2, Ranjan Dutta4,5
1Cleveland Clinic Genome Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
NPJ systems biology and applications
|November 5, 2024
概括
这项研究引入了一种新的网络医学方法,使用多omics数据来识别肌缩侧面硬化症 (ALS) 的新药标. 研究人员确定了像Diazoxide和Gefitinib这样的潜在治疗方法,为有效疗法提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 计算生物学 计算生物学
背景情况:
- 肌缩侧面硬化 (ALS) 是一种复杂的神经退行性疾病,治疗选择有限.
- 对ALS有效的治疗策略仍然是一个重要的未满足的医疗需求.
研究的目的:
- 开发一个网络医学框架,以确定新的药物标和可重复使用的ALS治疗方法.
- 利用多学科数据和网络分析来发现ALS的潜在治疗干预措施.
主要方法:
- 集成的人类大脑多omics数据,包括表达,蛋白质,剪接,甲基化和基因素乙化定量特征位置 (QTLs).
- 采用基于网络的深度学习框架来识别105个可能与ALS相关的基因.
- 在蛋白质-蛋白质相互作用网络上利用网络近距离分析来识别候选药物.
主要成果:
- 确定了105个涉及ALS病理生物学的候选基因.
- 优先考虑Diazoxide和Gefitinib作为潜在的可重复使用的药物用于ALS治疗.
- 临床前验证提供了证据,支持最先识别的药物的疗效.
结论:
- 基于网络的多omics方法可以有效地识别ALS的药物标和可重复使用的治疗方法.
- 这一框架有可能在其他神经退行性疾病中应用.
- 这些发现为开发新型ALS疗法提供了有希望的途径.
相关概念视频
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...